Medicine and Dentistry
Acute Heart Infarction
15%
Acute Respiratory Distress Syndrome
9%
Adverse Event
14%
Apoplexy
12%
Arm
9%
Asthma
46%
Atrial Fibrillation
9%
Biological Marker
34%
Body Mass Index
20%
Breast Cancer
51%
Cancer Risk
14%
Cardiac Catheterization
11%
Cardiomyopathy
11%
Cardiopulmonary Resuscitation
12%
Cardiovascular Disease
25%
Cardiovascular System
30%
Childbirth
11%
Chronic Obstructive Pulmonary Disease
41%
Clinical Trial
27%
Clinician
13%
Coccidioidomycosis
43%
Cohort Analysis
16%
Colorectal Cancer
11%
Combination Therapy
9%
Coronary Angiography
13%
Coronary Artery
12%
Coronary Artery Disease
14%
COVID-19
26%
Diabetes
17%
Diabetes Mellitus
14%
Diagnosis
20%
Dietary Pattern
9%
Disease
90%
Drug Therapy
18%
Endothelial Cell
10%
Forced Expiratory Volume
11%
Frailty
14%
Gene Expression
11%
Geriatrics
9%
Hazard Ratio
29%
Health Care Cost
18%
Heart Arrest
42%
Heart Failure
41%
Hemodynamic
16%
In Vitro
21%
Infarction
10%
Infection
39%
Injury
19%
Insulin Resistance
10%
Knee
20%
Knee Osteoarthritis
24%
Liver Cirrhosis
13%
Logistic Regression Analysis
12%
Magnetic Resonance Imaging
28%
Malignant Neoplasm
65%
Maturity Onset Diabetes of the Young
13%
Medicine
16%
Meta-Analysis
16%
Myocardial Infarction
25%
Neoplasm
29%
Nicotinamide Phosphoribosyltransferase
11%
Nodular Melanoma
11%
Obesity
14%
Observational Study
11%
Obstructive Sleep Apnea
17%
Odds Ratio
28%
Osteoarthritis
36%
Out of Hospital Cardiac Arrest
20%
Ovarian Cancer
18%
Overall Survival
9%
Pediatrics
18%
Percutaneous Coronary Intervention
18%
Personalized Medicine
12%
Physical Activity
36%
Placebo
19%
Platelet
9%
Positive Airway Pressure
9%
Postmenopause
36%
Prevalence
25%
Primary Health Care
10%
Proportional Hazards Model
9%
Prostate Cancer
9%
Public Health
11%
Pulmonary Hypertension
28%
Quality of Life
15%
Randomized Controlled Trial
15%
Resuscitation
68%
Saphenous Vein Graft
10%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Severe Asthma
14%
Single-Photon Emission Computed Tomography
10%
Skeletal Muscle
10%
Smoking
11%
Symptom
40%
Systematic Review
25%
Transplantation
17%
Ventricular Fibrillation
25%
Wellbeing
9%
Wheeze
13%
Women's Health
40%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
15%
Acute Heart Infarction
15%
Acute Lung Injury
9%
Adrenergic Receptor
7%
Adult Respiratory Distress Syndrome
11%
Adverse Event
19%
All Cause Mortality
10%
Antihypertensive Agent
6%
Asthma
42%
Atherogenesis
6%
Atrial Fibrillation
14%
Benzo(a)pyrene
16%
Biliary Tract Cancer
6%
Biological Marker
23%
Breast Cancer
26%
Captopril
8%
Carcinogenesis
6%
Cardiomyopathy
11%
Cardiovascular Disease
20%
Cell Culture
6%
Chemotherapy
12%
Chronic Obstructive Lung Disease
24%
Cisplatin
6%
Clinical Trial
29%
Coccidioides
7%
Coccidioides Immitis
9%
Coccidioidomycosis
42%
Cohort Study
16%
Colorectal Cancer
7%
Combination Therapy
13%
Comorbidity
11%
Coronary Artery Disease
13%
Coronavirinae
8%
Cytokine
8%
Diabetes Mellitus
9%
Digoxin
6%
Disease
100%
Dry Powder Inhaler
8%
Epileptic Absence
6%
Fibrosing Alveolitis
8%
Fluconazole
7%
Frailty
10%
Gemcitabine
6%
Glucocorticoid
6%
Heart Arrest
13%
Heart Arrhythmia
6%
Heart Failure
45%
Heart Failure with Preserved Ejection Fraction
12%
Heart Infarction
30%
Heart Left Ventricle Failure
7%
Heart Ventricle Fibrillation
10%
HIV
7%
Infarction
6%
Infection
37%
Inflammation
18%
Injury
16%
Insulin Resistance
8%
Ischemic Heart Disease
6%
Lipopolysaccharide
6%
Liver Cirrhosis
6%
Lung Cancer
8%
Lung Disease
9%
Malignant Neoplasm
33%
Melanoma
8%
Mouse
45%
Mouse Model
8%
Muscarinic Receptor
15%
Nanoparticle
6%
Neoplasm
21%
Nicotinamide Phosphoribosyltransferase
6%
Nitric Oxide
7%
Obesity
6%
Observational Study
6%
Opiate
9%
Opiate Receptor
14%
Osteoarthritis
7%
Out of Hospital Cardiac Arrest
6%
Ovary Cancer
12%
Overall Survival
9%
Paclitaxel
10%
Pharmacokinetics
13%
Phosphotransferase
8%
Pirenzepine
7%
Placebo
33%
Prevalence
17%
Progression Free Survival
11%
Pulmonary Hypertension
28%
Randomized Clinical Trial
7%
Randomized Controlled Trial
15%
Reactive Oxygen Metabolite
8%
Receptor
18%
SARS Coronavirus
12%
Sleep Disorder
6%
Sleep Disordered Breathing
17%
Spironolactone
7%
Sprague Dawley Rat
7%
Symptom
27%
Syndrome
7%
Turmeric
6%
Wheezing
7%
Keyphrases
Acute Myocardial Infarction
6%
African Ancestry
5%
Aging
6%
Arizona
10%
Asthma
26%
Atrial Fibrillation
5%
Body Composition
5%
Body Mass Index
14%
Breast Cancer
9%
Cancer Survivors
5%
Cardiac Arrest
13%
Cardiopulmonary Resuscitation
13%
Cardiovascular Disease
11%
Central Nervous System
6%
Chaperone-rich Cell Lysate
5%
Chemotherapy
6%
Chest Compression
9%
Chronic Obstructive Pulmonary Disease
16%
Clinical Outcomes
5%
Clinical Trials
11%
Coccidioides Immitis
10%
Coccidioidomycosis
37%
Comorbidity
5%
Confidence Interval
26%
Congestive Heart Failure
5%
Coronary Angiography
7%
Coronary Artery Disease
8%
COVID-19
10%
Cytomegalovirus
5%
Diabetes
7%
Forced Expiratory Volume in 1 Second (FEV1)
6%
Frailty
7%
Hazard Ratio
14%
Heart Failure
14%
Heart Failure with Preserved Ejection Fraction (HFpEF)
7%
High Risk
8%
Hispanic
6%
Hypertension
5%
Improved Outcomes
5%
In Cancer
6%
Insomnia
6%
Insulin
9%
Insulin Resistance
7%
Knee Osteoarthritis
7%
Left Ventricular Function
7%
Lung
10%
Lung Function
10%
Meta-analysis
6%
Muscarinic Cholinergic Receptor
5%
Muscarinic Receptors
9%
Myocardial Infarction
11%
Obesity
13%
Obstructive Sleep Apnea
6%
Odds Ratio
12%
Older Adults
12%
Opioid Receptors
7%
Osteoarthritis
7%
Osteoarthritis Initiative
5%
Out-of-hospital Cardiac Arrest
10%
Overall Survival
7%
Percutaneous Coronary Intervention
6%
Phosphorylation
7%
Physical Activity
14%
Pirenzepine
6%
Placebo
13%
Postmenopausal Women
18%
Precision Medicine
5%
Protein Kinase
5%
Pulmonary Arterial Hypertension
8%
Pulmonary Hypertension
8%
Quality of Life
7%
Race-ethnicity
5%
Randomized Clinical Trial
7%
Randomized Controlled Trial
5%
Randomized Trial
6%
Resuscitation
7%
Risk Factors
12%
Severe Asthma
8%
Sleep Duration
8%
Sleep Health
5%
Soleus muscle
5%
Survivors
5%
Systematic Meta-analysis
6%
T Cells
6%
Trauma Resuscitation
7%
Tucson
6%
Tumor
7%
Type 1 Diabetes Mellitus (T1DM)
5%
Type 2 Diabetes Mellitus (T2DM)
5%
United States
13%
Vascular Smooth muscle Cells
5%
Ventricular Fibrillation
8%
Women's Health Initiative
28%